browse Browse

pac.dog pac.dog / Lobbying

1st Quarter - Report · 2026

Filing UUID
032bce27-9464-4ebb-846a-f1cbb03e9fc7
Type
Q1 — 1st Quarter - Report
Period
first_quarter
Year
2026
Posted
2026-04-20 14:32:40
Income (reported)
—
Expenses (reported)
—
Filing document
Open on lda.senate.gov
Registrant (lobbying firm)

BUCHANAN INGERSOLL & ROONEY PC

law firm

Contact
WILL LE
Phone
+1 202-452-5783
Address
zip:20006, city:Washington, state:DC, street:1700 K Street, NW Suite 300
Client

GENERIC ANIMAL DRUG ALLIANCE

Professional trade association for generic animal drug products.

State
MD
Country
US
Government-entity client
false
Effective date
2021-01-01
Issues lobbied + lobbyists (4)

ANI — Animals

Strategy development and implementation of federal government relations initiatives relating to generic animal drug industry. H.R. 1683, the Generic Animal Drug Advancement Act, all provisions; H.R. 1418, the Animal Drug User Fee Amendments of 2023, all provisions

Lobbyists:

Government entities lobbied: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE

HCR — Health Issues

Strategy development and implementation of federal government relations initiatives relating to generic animal drug industry. H.R. 1683, the Generic Animal Drug Advancement Act, all provisions; H.R. 1418, the Animal Drug User Fee Amendments of 2023, all provisions

Lobbyists:

Government entities lobbied: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE

MED — Medical/Disease Research/Clinical Labs

Strategy development and implementation of federal government relations initiatives relating to generic animal drug industry. H.R. 1683, the Generic Animal Drug Advancement Act, all provisions; H.R. 1418, the Animal Drug User Fee Amendments of 2023, all provisions

Lobbyists:

Government entities lobbied: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE

PHA — Pharmacy

Strategy development and implementation of federal government relations initiatives relating to generic animal drug industry. H.R. 1683, the Generic Animal Drug Advancement Act, all provisions; H.R. 1418, the Animal Drug User Fee Amendments of 2023, all provisions

Lobbyists:

Government entities lobbied: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE

pac.dog is a free, independent, non-partisan research tool. Every candidate, committee, bill, vote, member, and nonprofit on this site is mirrored from primary U.S. government sources (FEC, congress.gov, govinfo.gov, IRS) and each state's Secretary of State / election commission — no third-party data vendors, no paywall, no editorial intermediation. Citations to the originating source are on every detail page.